Cargando…
The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy
Hepatocellular carcinoma (HCC) is the major subtype of liver cancer, which ranks sixth in cancer incidence and third in mortality. Although great strides have been made in novel therapy for HCC, such as immunotherapy, the prognosis remains less than satisfactory. Increasing evidence demonstrates tha...
Autores principales: | Guizhen, Zhang, Guanchang, Ji, Liwen, Liu, Huifen, Wang, Zhigang, Ren, Ranran, Sun, Zujiang, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452721/ https://www.ncbi.nlm.nih.gov/pubmed/36093115 http://dx.doi.org/10.3389/fendo.2022.918869 |
Ejemplares similares
-
RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma
por: Rao, Benchen, et al.
Publicado: (2021) -
PRRC2A Promotes Hepatocellular Carcinoma Progression and Associates with Immune Infiltration
por: Liu, Xin, et al.
Publicado: (2021) -
Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023) -
Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy
por: Feng, Hai, et al.
Publicado: (2022) -
Obstacles and Coping Strategies of CAR-T Cell Immunotherapy in Solid Tumors
por: Miao, Lele, et al.
Publicado: (2021)